Pay in 4 interest-free payments of $6.61 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
CrossRef Non-invasive diagnosis and staging of non-alcoholic fatty liver disease Stergios Kechagias, Mattias Ekstedt, Christian Simonsson, Patrik Nasr Hormones.2022
a phase I/II trial in 36 patients with heavily-pretreated mCRPC demonstrated a 14.3% objective response rate, a 95.2% disease control rate, and improvements in PSA levels, as well as a manageable safety profile with cytopenias as the most common grade 3 TRAE (CTR20231298) 101
Exp Cell Res 317:27022710 Chakrabarti S, Liehl P, Buchon N, Lemaitre B (2012) Infection-induced host translational blockage inhibits immune responses and epithelial renewal in the Drosophila gut
If available, keep it
Exenatide twice daily: a review of its use in the management of patients with type 2 diabetes mellitus
US$ 23.73
US$ 23.98
US$ 21.27
US$ 27.47
